Tuesday was a busy day in the upper managerial ranks of Co-Diagnostics (NASDAQ: CODX). The molecular diagnostics specialist appointed both a new CFO and a new chief science officer (CSO). The former is Brian Brown, who replaces current office holder Reed Benson. Brown has served in a range of financial positions in his career, including a more than 10-year stint at Sportsman's Warehouse, where he was director of finance for most of that time. The company said Benson will remain with it as a general counsel. Image source: Getty Images. Co-Diagnostics' new CSO is Jesse Montgomery, who was previously its senior vice president of biochemistry, a position he took up last September. He originally joined Co-Diagnostics that June as its vice president of research. Montgomery replaces Brent Satterfield, the company's founder. Similar to outgoing CFO Benson, Satterfield will also stay with Co-Diagnostics. In his case, he will serve as the head of its scientific advisory board. In the press release heralding the executive changes, Co-Diagnostics said that they "[follow] significant growth in the past year and in anticipation of additional growth in the future." On the back of sudden prominence related to its COVID-19 diagnostic solutions, the company's stock has been on fire, rising by nearly 1,000% in 2020. With that kind of performance, investor expectations are high, and the company appears to be gearing up to meet them. That said, its shares fell by over 5% on Tuesday, against the slight (0.1%) gain of the S&P 500 index. 10 stocks we like better than Co-Diagnostics, Inc.When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Co-Diagnostics, Inc. wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of November 20, 2020 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.Source